P-ISSN 2587-2400 | E-ISSN 2587-196X
Contact
EJMO Home
|
Toggle navigation
EJMO HOME
ABOUT JOURNAL
EDITORIAL BOARD
INSTRUCTIONS FOR AUTHORS
FOR REVIEWERS
EJMO ARCHIVE
CONTACT
EJMO Volume :
6
Issue :
1
Year :
2022
COVID-19 in EJMO
6/1
EJMO Current Issue
EJMO Archive
EJMO & Congress of Oncology and immunotherapy association
Most Cited Articles
Ahead of Print
Most Accessed Articles
Copyright Transfer Form
ICMJE COI Form
EJMO Sponsors
Arven
Amgen
Astellas
Bristol-Myers Squibb
Johnson Johnson
Merck
Pfizer
Novartis
Omnigen
Mustafa Nevzat
Roche
TEVA
Trpharm
Page not found.
EJMO Citations
Number of Citations:
1549
Number of Articles:
263
Accept Ratio : 18.2 %
Days from submission to final decision 26.5
EJMO NLM ID:
101720527
Our Other Journal
EJMI
Quick Search
In authors and institutes
In titles and abstracts
In keywords
In all
Copyright © 2022 Eurasian Journal of Medicine and Oncology, EJMO
EJMO & EJMO